Stromacel
PROT · OTC
About PROT
- Employees
- 1
- Headquarters
- Mountainside, New Jersey
- Listed
- Jul 31, 1997
- Sector
- Health Care
- Industry
- Biotechnology
PROT key statistics
- Market cap
- 2.28K
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 21.03K
- Volume
- 3.61K
- Open price
- $0.0001
- High today
- $0.0001
- Low today
- $0.0001
- 52 Week high
- $0.0001
- 52 Week low
- $0.00
Stromacel (PROT) at a glance
Stromacel (PROT) last traded at $0.0001, with a market cap of 2.28K.
Volume so far is 3.61K shares, below the average of 21.03K shares a day.
Over the past year Stromacel has ranged from $0.00 to $0.0001, and now sits 100% of the way up that range.
Similar companies
Companies in the same industry as Stromacel
Most active stocks
Highest trading volume today
- SHFSSHF Holdings$0.0899−4.36%
- WHLRWheeler Real Estate Investment Trust$0.3597+2.19%
- SDSTStardust Power$0.02−23.66%
- RBNERobin Energy$0.3978−23.65%
- RCTRedCloud Holdings$0.084+1.94%
- WFFWF Holding$0.0929−3.83%
- NWGLCL Workshop Group$0.1522+27.90%
- KORUDirexion Shares ETF Trust$11.34−4.87%
- DKIDarkiris$0.0479−6.08%
- AHTAshford Hospitality Trust$1.79−2.72%
- SOXLDirexion Shares ETF Trust$97.55−1.12%
- SOXSDirexion Shares ETF Trust$47.13+1.07%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.